2025-05-08 LabMCoP Meeting Notes

Date

May 8, 2025

Attendees

Present	Name	Organization

Present	Name	Organization
-	Nancy Cornish	CDC
-	Manjula Gama-Ralalage	CDC
X	Riki Merrick	APHL
X	Christina Gallegos	APHL
-	Amy Liu	Inductive Health / APHL
-	Raj Dash	Duke / CAP
X	John Snyder	National Library of Medicine (SNOMED CT)
X	Andrea Pitkus	UW
X	Kathy Walsh	Labcorp
-	Rob Hausam	Hausam Consulting
	Pam Banning	3M

Discussion topics

Upcoming OOO		Reminder: We are now using https://aphlinformatics.atlassian.net/wiki/spaces/LMCOPL/calendars and everyone can just keep it updated NOTE: you will need to use type “Event” if you do not have a confluence account No calls May 15 and May 22
CSTE Presentation	Riki - no update	CSTE ELR call presentation on wound cultures and Specimen CMT (modeled for ELR) by Nancy, Riki, and Manjula has been postponed to a TBD date later
Specimen CMT - review of terms with questions	Christina/Amy	Follow up items: stool with 10% formalin - would this work for SPM 6? 464601000124100 \| Modified polyvinyl alcohol with copper sulfate and ten percent formalin (product) - Nancy said she will take a look Serum_Thrombin_Gel - need more info about the gel - SCT has 702281005 \| Evacuated blood collection tube with thrombin and clot activator and gel separator (physical object) \| - Christina email follow up with John when she sends the list of Ask Jen from Arup, who submitted the blood tube types, how she is using these (if only in compendium, or expecting to come in as part of order): ANSWER: It can be helpful to have the container, for example when it is protecting the sample from light, it contains additives (urine), uses a specific collection kit (aptima), or is phlebotomy. This (the submission of container types) was in preparation for using them within our compendium. I would like to get to a point where we communicate to our clients what we would expect in the SPM segment, but we aren't there yet and many of our clients are still sending 2.3.1. often times the lab will create collection kits, where they add the additives to containers and provide those to customers, or it is part of the described collection procedure, especially for lab developed tests for blood tubes, they are usually commercial products SPM-27 for container type we don't currently have in the CMT, but it is O in LOI and LRI SPM-6 is RE in ELR, but O in LOI and LRI - currently have deconstructed commercial containers into additives in the CMT - will have to revist, if we add container type for breast cancer testing knowing all the additives is important, currently covered by AOEs, as often also need to know duration of additive exposure (usually at time of collection) - here are some https://arup.utah.edu/media/breast_cancer_guidelines/Hammond GR Jan 21 11.pdf sometime the additives are added at later point in time NHSN term - Riki to ask Nancy if we have the latest yet
Creating Value Sets for specimen related attributes	John	US valuesets should be in VSAC for all clinical care Value sets that are used in HL7 should be in International RefSets (and are probably easier to migrate, if they already exist in VSAC (but would need to make sure we promote US extension terms first) Specimen reject reason table review - OO decided that when the reject reason is a specimen condition, we should use the SAME concepts, so review with that in mind review the “unsatisfactory for evaluation due to …” concepts Containers (EU review work might have some new content - Reached out to Feijke for update - here is the latest file Additives (Nancy reviewing the stool preservatives)
LOINC common maps		Charlie shared the LOINC mapings and the unmapped strings (will email to this group) most common is Lab interpretation (https://loinc.org/56850-1 ) https://loinc.org/77202-0 or https://loinc.org/19146-0 bring up all the comment LOINCs and mappings Some folks use the doc LOINC when they are not sending the discrete data, but just the pdf https://loinc.org/11502-2 https://loinc.org/107138-0 but some are using the panel code for these, which they shoudl not, as it intermingles discrete with non-structured results Doc ontology review is part of the LOINC ontology work, the doctypes are currently under the clinical class, maybe we could map them to the correct domain? Should check up with Charlie to see, if he knows where the LOINCs using the shorname in the description come from - as that is discouraged
Call Adjourned		11:56 AM ET Next call is May 29th
Previous Action Items	Not discussed	Nancy Follow up: EDTA Stopper top EDTA sufficient or do we need to specify K2 or K3? - yes! Nancy can review the list in SNOMED from John Need to check on completeness against the Anne/Nancy list (compare with ARUP) Nancy/Anne’s list is 10 years old - may not want to compare with this outdated list and use ARUP and Labcorp lists Raj: I found this at a phlebotomy certification course website: What Color Tubes Are Used for Which Tests in Phlebotomy – PhlebotomyU Here's a nice one-pager (University of Colorado Health): https://www.testmenu.com/universityhospital/TestDirectory/SiteFile?fileName=sidebar\CLNLAB-2020-03-13-Blood-Tube-Color-Chart.pdf Cleveland Clinic: Blood Collection Tubes - Collection \| Cleveland Clinic Laboratories https://phlebotomygeeks.yolasite.com/resources/PRINT OUT COMMON TUBES.pdf but color is manufacturer dependent, which is why we named the tubes by the additives there are container types in SNOMED under 706049005 \|Blood tube (physical object)\| Have a start here: https://aphlinformatics.atlassian.net/wiki/download/attachments/2018312270/ContainertypesListRikiEmailed20171013.xlsx?api=v2 K1 or K2 might be important to differentiate We should leave the top color out of it, since that is manufacturer specific Nancy will see, if their fellow has time to review and complete the list for us (she is a phlebotomist ) Contact United Network for Organ Sharing for input on donor terms (pre-coordinated or not?) = ISBT 128 \| ICCBBA \| Technical Documents https://www.isbt128.org/_files/ugd/1a7593_edfd176861c94dca94c34eff8fa3ad0d.pdf - for organs Might be a topic for SNOMED International We may need to reach out to laboratories/industry to see if the donor codes are needed (we need to show that these codes are needed.) Riki has some contact now with European bloodbank and biobanks = Home - BBMRI-ERIC working with the folks that define their minimum data set: MIABIS - BBMRI-ERIC - these folks shared the follwoing for the reject reason topic, but it seems they differentiate between source site and the organ: #1 Standard PREanalytical Code Version 4.0 - (version 3.0 is here: https://cdn.ymaws.com/www.isber.org/resource/resmgr/isber_2019/pdf/standard_preanalytical_code_.pdf) Riki’s Follow up - none of these got done yet Riki to set up her VSAC authoring log in Connect with CAP Informatics Committee (Riki can email Kevin Schap) and ASCP (does anyne have a connection?) liquid-based cytology specimen vial = https://us-request.ihtsdotools.org/#/requests/preview/354843?fromList=truehttps://request.ihtsdotools.org/#/requests/edit/786429 submit a code for formalin10 work with John new term for pacemaker insertion site sample in SCT there are only swabs for insertion sites (line, drain, chest tube, vascular catheter) - this should be fixed we should model it after 435971000124108 \| Body fluid specimen from peritoneal dialysis insertion site (specimen) and require method, which should be aspirate For wound modeling (see 2023-11-30 LabMCoP Meeting Notes ) create a few pre-coordinated specimen terms to cover the wound causes as children under: 119365002 \| Specimen from wound (specimen) another child term for aspirate under 445611000124106 \| Specimen from bite wound (specimen), since that is preferred over the existing swab
Specimen CMT - Hosting Options	Not discussed	How can we publish the content in the dB? Allow access somehow to query the dB as access or excel or csv Using FHIR conceptMap similar to Conceptmap-example-specimen-type - FHIR v6.0.0-cibuild - based on this profile: ConceptMap - FHIR v6.0.0-cibuild SNOMED CT Extension and use of RefSets (start with VSAC value sets as proof of concept and then migrate over) to indicate: preferred specimen types by domain maybe also terms that need additional attributes (by kind of attribute) if we also write an implementation guide for it How do we decide what format to share this in - get input from EHR-s and LIS vendors: Write letter of mulitple stakeholders to request EHR-s and LIS vendors to implement indicating that this is a patient safety issue, as incorrect Abx treatment will contribute to multi-drug resistance (use CTSI findings to provide background) focus on blood, urine, wound cultures (get data from NHSN, too) Nancy is talking to DHQP about the linkage with specimen collection While we have HIT certification that is for the EHR-s there is currently no enforcement for implementation at the organizations need C-suite buy-in Professional organizations - like CAP and ACOS and AJCC get them to write the synoptic reports (better structuring of data) - for surgical aspects - similar to what CAP has done for Cancer (though they do not have the SCT codes included in the past - may be including SNOMED CT starting in 2025, but they are also using the SCT codes for observables) Synoptic reporting for cancer surgery: Current requirements and future state: The four CoC accreditation standards that include synoptic operative reporting requirements apply to sentinel lymph node biopsy for breast cancer (Standard 5.3), axillary lymph node dissection for breast cancer (Standard 5.4), wide local excision for primary cutaneous melanoma (Standard 5.5), and colonic resection for colon cancer (Standard 5.6). These accreditation standards were developed from the evidence-based recommendations for cancer surgery detailed in the Operative Standards for Cancer Surgery manuals.7,8 try to get AMA support to get providers to adopt this Reach out to IDSA, too
Specimen CMT pilot implementers	Not discussed	Review where we are: Vendor Connections no update
Specimen CMT - education	Not discussed	Need education for providers and IT folks that helps with set up of the EHR-S / LIS configuration -this can be supported / accomplished? with the Implementaiton Guide we could write if we have a use case of how a patient is impacted on their journey through the healthcare system - CAP created a nice video that showed how patient care was affected by incorrect data SHIELD FDA BAA Year 2
Specimen CMT - tracking implementation impact Setting baseline Define metrics	Not discussed
Specimen CMT - Compare to NHS Medical Terminology testing	Not discussed	Will get updated vocab at a later date
Future projects for this call after CMT	Not discussed	In general the call is intended as a forum for ANY messaging related issues to work out. In the past we have reviewed containers re-vive that - and how does that interact with devices (UDI identification?) review code systems around additives (HL70371 and SCT substance and product hierarchies) started work on cross-mapping between HL7 method codes and SNOMED CT procedure / technique concepts American College of Surgeons is working on procedure protocol and synoptic data elements / surgical synoptic reports - we could work with them together on that Look at other HL7 tables that we would want to migrate SCT (i.e., Specimen Condition table, etc.)

Recording:

Per APHL policy we are not currently allowed to record any meetings

From Chat

Action items

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.